EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
-9.82%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$382M
AUM Growth
-$165M
(-30%)
Cap. Flow
-$66.4M
Cap. Flow
% of AUM
-17.37%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$66.4M |
Sector Composition
| 1 | Healthcare | 95.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $137M | 35.98% |
1,450,000
-700,000
| -33% | -$66.4M |
|
|
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
| $80.2M | 20.98% |
4,592,047
| – | – |
|
|
ENTL
3
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $69.4M | 18.15% |
3,813,197
| – | – |
|
|
CORI
4
DELISTED
Corium International, Inc.
CORI
| $36.1M | 9.45% |
9,353,304
| – | – |
|
5
Axogen
AXGN
$774M
| $26.1M | 6.82% |
4,861,111
| – | – |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $16.8M | 4.39% |
125,747
| – | – |
|
7
MediciNova
MNOV
$60.3M
| $8.59M | 2.25% |
1,170,370
| – | – |
|
|
ACUR
8
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $5.54M | 1.45% |
1,956,397
| – | – |
|
9
Gyre Therapeutics
GYRE
$687M
| $2.02M | 0.53% |
10,483
| – | – |
|